These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
161 related articles for article (PubMed ID: 35295834)
1. Regulatory B Cells Are Decreased and Functionally Impaired in Myasthenia Gravis Patients. Lin Y; Chang T; Lin J; Sun C; Wei C; Zhao J; Liu R; Yang K; Li Z Front Neurol; 2022; 13():808322. PubMed ID: 35295834 [TBL] [Abstract][Full Text] [Related]
2. Interleukin-35 promotes Breg expansion and interleukin-10 production in CD19 Zhang Y; Wei S; Wu Q; Shen X; Dai W; Zhang Z; Chen M; Huang H; Ma L Clin Rheumatol; 2022 Aug; 41(8):2403-2416. PubMed ID: 35420296 [TBL] [Abstract][Full Text] [Related]
3. Comparison of peripheral blood B cell subset ratios and B cell-related cytokine levels between ocular and generalized myasthenia gravis. Hu Y; Wang J; Rao J; Xu X; Cheng Y; Yan L; Wu Y; Wu N; Wu X Int Immunopharmacol; 2020 Mar; 80():106130. PubMed ID: 31978800 [TBL] [Abstract][Full Text] [Related]
4. CD19 Chen Q; Lai L; Chi X; Lu X; Wu H; Sun J; Wu W; Cai L; Zeng X; Wang C; Chen W; Peng A Mediators Inflamm; 2020; 2020():3019378. PubMed ID: 32104147 [TBL] [Abstract][Full Text] [Related]
5. Reduced peripheral blood regulatory B cell levels are not associated with the Expanded Disability Status Scale score in multiple sclerosis. Guo S; Chen Q; Liang X; Mu M; He J; Fang Q; Song C; Sang D J Int Med Res; 2018 Sep; 46(9):3970-3978. PubMed ID: 30025488 [TBL] [Abstract][Full Text] [Related]
6. Peripheral regulatory cells immunophenotyping in primary Sjögren's syndrome: a cross-sectional study. Furuzawa-Carballeda J; Hernández-Molina G; Lima G; Rivera-Vicencio Y; Férez-Blando K; Llorente L Arthritis Res Ther; 2013; 15(3):R68. PubMed ID: 23800367 [TBL] [Abstract][Full Text] [Related]
7. B cell subsets and dysfunction of regulatory B cells in IgG4-related diseases and primary Sjögren's syndrome: the similarities and differences. Lin W; Jin L; Chen H; Wu Q; Fei Y; Zheng W; Wang Q; Li P; Li Y; Zhang W; Zhao Y; Zeng X; Zhang F Arthritis Res Ther; 2014 May; 16(3):R118. PubMed ID: 24887143 [TBL] [Abstract][Full Text] [Related]
8. Characterization of CD19 Gu Y; Li K; Sun J; Zhang J J Eur Acad Dermatol Venereol; 2020 Dec; 34(12):2863-2870. PubMed ID: 32242984 [TBL] [Abstract][Full Text] [Related]
9. Elevated circulating CD19 Deng B; Deng L; Liu M; Zhao Z; Huang H; Tu X; Liang E; Tian R; Wang X; Wang R; Lin H; Yu Y; Peng A; Xu P; Bao K; He M Immunol Lett; 2023 Sep; 261():58-65. PubMed ID: 37553031 [TBL] [Abstract][Full Text] [Related]
10. Defective CD19+CD24 Cencioni MT; Ali R; Nicholas R; Muraro PA Mult Scler; 2021 Jul; 27(8):1187-1197. PubMed ID: 32924828 [TBL] [Abstract][Full Text] [Related]
11. Effect of CD40/CD40L signaling on IL-10-producing regulatory B cells in Chinese children with Henoch-Schönlein purpura nephritis. Yang B; Tan X; Xiong X; Wu D; Zhang G; Wang M; Dong S; Liu W; Yang H; Li Q Immunol Res; 2017 Jun; 65(3):592-604. PubMed ID: 27837410 [TBL] [Abstract][Full Text] [Related]
12. CD19(+)CD24(hi)CD38(hi) B cells exhibit regulatory capacity in healthy individuals but are functionally impaired in systemic Lupus Erythematosus patients. Blair PA; Noreña LY; Flores-Borja F; Rawlings DJ; Isenberg DA; Ehrenstein MR; Mauri C Immunity; 2010 Jan; 32(1):129-40. PubMed ID: 20079667 [TBL] [Abstract][Full Text] [Related]
13. Loss of Gαq impairs regulatory B-cell function. He Y; Yuan X; Li Y; Zhong C; Liu Y; Qian H; Xuan J; Duan L; Shi G Arthritis Res Ther; 2018 Aug; 20(1):186. PubMed ID: 30143054 [TBL] [Abstract][Full Text] [Related]
14. The skewed frequency of B-cell subpopulation CD19 Wang H; Liu C; Chen W; Ding G J Cell Biochem; 2019 Jul; 120(7):11490-11497. PubMed ID: 30771230 [TBL] [Abstract][Full Text] [Related]
15. Breg Cells Are Numerically Decreased and Functionally Impaired in Patients With Systemic Sclerosis. Mavropoulos A; Simopoulou T; Varna A; Liaskos C; Katsiari CG; Bogdanos DP; Sakkas LI Arthritis Rheumatol; 2016 Feb; 68(2):494-504. PubMed ID: 26414243 [TBL] [Abstract][Full Text] [Related]
16. Reduced CD5(+) CD24(hi) CD38(hi) and interleukin-10(+) regulatory B cells in active anti-neutrophil cytoplasmic autoantibody-associated vasculitis permit increased circulating autoantibodies. Aybar LT; McGregor JG; Hogan SL; Hu Y; Mendoza CE; Brant EJ; Poulton CJ; Henderson CD; Falk RJ; Bunch DO Clin Exp Immunol; 2015 May; 180(2):178-88. PubMed ID: 25376552 [TBL] [Abstract][Full Text] [Related]
17. Regulatory B cells (CD19(+)CD38(hi)CD24(hi)) in alloimmunized and non-alloimmunized children with β-thalassemia major. Zahran AM; Elsayh KI; Saad K; Embaby M; Ali AM Blood Cells Mol Dis; 2016 Mar; 57():91-6. PubMed ID: 26852663 [TBL] [Abstract][Full Text] [Related]
18. Restoration of regulatory B cell deficiency following alemtuzumab therapy in patients with relapsing multiple sclerosis. Kim Y; Kim G; Shin HJ; Hyun JW; Kim SH; Lee E; Kim HJ J Neuroinflammation; 2018 Oct; 15(1):300. PubMed ID: 30373595 [TBL] [Abstract][Full Text] [Related]
19. The correlation of CD19 + CD24 + CD38 + B cells and other clinicopathological variables with the proportion of circulating Tregs in breast cancer patients. Gheybi MK; Farrokhi S; Ravanbod MR; Ostovar A; Mehrzad V; Nematollahi P Breast Cancer; 2017 Nov; 24(6):756-764. PubMed ID: 28429331 [TBL] [Abstract][Full Text] [Related]
20. Circulating plasmablasts/plasma cells: a potential biomarker for IgG4-related disease. Lin W; Zhang P; Chen H; Chen Y; Yang H; Zheng W; Zhang X; Zhang F; Zhang W; Lipsky PE Arthritis Res Ther; 2017 Feb; 19(1):25. PubMed ID: 28183334 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]